Alan Au
Gründer bei GT Capital Investment Ltd.
Aktive Positionen von Alan Au
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
GT Capital Investment Ltd.
 GT Capital Investment Ltd. Investment ManagersFinance GT Capital Investment Ltd. is an Independent Private Equity/Venture Capital firm founded in 2013 by Alan Au. GT Capital Investment Ltd. is headquartered in Hong Kong. | Gründer | 01.01.2013 | - |
| Private Equity Investor | 01.01.2013 | - | |
Oxford Investment Consultants LLP
 Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London. | Berater | - | - |
G.I. Windows, Inc.
 G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Alan Au
Ehemalige bekannte Positionen von Alan Au
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cellular Biomedicine Group (Shanghai) Ltd.
 Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.11.2014 | 01.02.2021 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.12.2019 | - |
Ausbildung von Alan Au
| The Chinese University of Hong Kong | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Hong Kong | 3 |
| China | 3 |
Operativ
| Director/Board Member | 3 |
| Founder | 1 |
| Private Equity Investor | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
G.I. Windows, Inc.
G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Health Technology |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London. | Finance |
Cellular Biomedicine Group (Shanghai) Ltd.
Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China. | Health Technology |
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Capital Investment Ltd. is an Independent Private Equity/Venture Capital firm founded in 2013 by Alan Au. GT Capital Investment Ltd. is headquartered in Hong Kong. | Finance |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |